These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1026071)

  • 61. Effect of progestational agents on carcinoma of the prostate.
    Geller J; Fruchtman B; Newman H; Roberts T; Silva R
    Cancer Chemother Rep; 1967 Feb; 51(1):41-6. PubMed ID: 6039663
    [No Abstract]   [Full Text] [Related]  

  • 62. Flare reaction during the initial treatment period with medroxyprogesterone acetate in patients with hormone-resistant prostatic cancer.
    Fosså SD; Urnes T
    Eur Urol; 1986; 12(4):257-9. PubMed ID: 3743595
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Progestogens in prostatic cancer.
    Denis L; Declercq G
    Eur Urol; 1978; 4(3):162-6. PubMed ID: 658069
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medroxyprogesterone in in-vitro fertilisation.
    Yovich JL; Stanger JD; Willcox DL; Michael CA
    Lancet; 1983 Mar; 1(8326 Pt 1):711. PubMed ID: 6132069
    [No Abstract]   [Full Text] [Related]  

  • 65. Medroxyprogesterone for acromegaly.
    Atkinson RL
    JAMA; 1973 Jan; 223(4):442. PubMed ID: 4739130
    [No Abstract]   [Full Text] [Related]  

  • 66. [Treatment of prostatic cancer].
    Nihon Hinyokika Gakkai Zasshi; 1965 Sep; 56(9):963-7. PubMed ID: 5893473
    [No Abstract]   [Full Text] [Related]  

  • 67. Editorial: Prostatic cancer: policies ofr progress.
    Br Med J; 1976 Aug; 2(6034):490-1. PubMed ID: 953640
    [No Abstract]   [Full Text] [Related]  

  • 68. [Pop the Champagne].
    Nordby OP
    Tidsskr Nor Laegeforen; 2012 Jan; 132(1):11. PubMed ID: 22240816
    [No Abstract]   [Full Text] [Related]  

  • 69. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S; Johnson R
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):261-7. PubMed ID: 4208339
    [No Abstract]   [Full Text] [Related]  

  • 70. [High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
    Flamm J; Spona J
    Wien Klin Wochenschr; 1987 Oct; 99(19):682-6. PubMed ID: 2961131
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer].
    Sasagawa I; Satomi S; Umeda K; Katayama T
    Hinyokika Kiyo; 1989 Apr; 35(4):603-8. PubMed ID: 2525316
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of prostatic cancer with progestational agents].
    Bouffioux C
    Acta Urol Belg; 1976 Oct; 44(4):336-53. PubMed ID: 1026071
    [No Abstract]   [Full Text] [Related]  

  • 74. An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
    Robustelli della Cuna G; Zanon P; Pavesi L; Preti P; Prada GA; Decensi A
    Chemioterapia; 1986 Jun; 5(3):164-72. PubMed ID: 2941173
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.